Blood Flow Restriction Following Hip Arthroscopy
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Rush University Medical Center
- Study ID
- NCT04113759
- Status
- Recruiting
Conditions
- Femoral Acetabular Impingement
- Labral Tear, Glenoid
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 40 Years
- Healthy Volunteers
- Accepted
Interventions
- Blood Flow Restriction Rehabilitative Therapy — BEHAVIORALBFR cuffs placed at the proximal thigh, just inferior to the greater trochanter. Inflation time not to exceed 20 minutes. One BFR session per treatment. BFR exercise dosage: 4 sets of the following repetitions 30, 15, 15, 15, 30 second rest between sets, 1 min rest between exercises. Progress exercise if pain \<2/10 on VAS and RPE \<5 on 0-10 scale. (Heerey et al), and no break down in form.
- Sham BFR Rehabilitative Therapy — BEHAVIORALThe schedule, type of exercises, repetition ranges, and other physical therapy interventions will be the same as the BFR experimental group - however a non-occlusive pressure will be applied with the cuff in the control group.
Study Details
This study will be a prospective randomized, double-blinded, placebo-controlled trial of patients undergoing primary hip arthroscopy for FAIS and/or labral pathology. All patients who sign the consent form will be enrolled in the study and randomized to one of the two treatment arms. Follow-up will take place at 1-month, 3-months, 6-months, and 1-year.
Key Dates
- Start date
- Aug 1, 2023
- Status verified
- Dec 2025
- Primary completion
- Nov 30, 2027
- Completion
- Jan 31, 2028
Study Design
- Enrollment
- 56 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: Control GroupThe control group will receive sham BFR, in which a non-occlusive pressure is applied with the cuff. The exercises performed will be identical to the BFR group.
- Experimental: BFR Postoperative RehabilitationThe experimental group will receive BFR postoperative rehabilitation, which will involve performing a series of blood flow restriction exercises identical to the control group.
Primary Outcome Measure
Quadriceps Strength [ Time Frame: 3 month time point ]
Central Contacts
- Carla M. Edwards, PhD312-563-5735
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Rush University Medical Center | Chicago | Illinois | 60612 |
Find similar trials in Chicago, IL
By research site
Related Studies
- Hip Arthroscopy Postoperative Opioid DemandsRecruiting · Rush University Medical Center · Chicago, Illinois